Technetium-99m-labeled poly(dl-Lactide-co-Glycolide) nanoparticles as an alternative for sentinel lymph node imaging

Cancer Biotherapy and Radiopharmaceuticals

Volumn 25, Issue 6, 2010, Pages 637-644

  Subramanian, Suresh ^a   Dandekar, Prajakta ^b   Jain, Ratnesh ^b   Pandey, Usha ^a   Samuel, Grace ^a   Hassan, Puthusserickal Abdulrahiman ^a   Patravale, Vandana ^b   Venkatesh, Meera ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Imaging; metastasis; nanoparticles; PLGA; sentinel lymph node; SLND

Indexed keywords

CRYOPROTECTIVE AGENT; GLUCOSE; MANNITOL; NANOPARTICLE; POLOXAMER; POLY(DEXTROLEVO LACTIDE CO GLYCOLIDE) TECHNETIUM 99M; RADIOPHARMACEUTICAL AGENT; TREHALOSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD; DRUG DISTRIBUTION; DRUG UPTAKE; FREEZE DRYING; HEART; IN VIVO STUDY; INTESTINE; KIDNEY; LIVER; LUNG; MALE; MUSCLE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RADIODIAGNOSIS; RAT; SCINTIGRAPHY; SENTINEL LYMPH NODE; SPLEEN; STOMACH;

ANIMAL STRUCTURES; ANIMALS; CRYOPROTECTIVE AGENTS; FEMALE; FREEZE DRYING; ISOTOPE LABELING; LACTIC ACID; LYMPH NODES; MICROSCOPY, ATOMIC FORCE; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; RADIONUCLIDE IMAGING; RATS; RATS, WISTAR; SENTINEL LYMPH NODE BIOPSY; SURFACE-ACTIVE AGENTS; TECHNETIUM; TISSUE DISTRIBUTION; VITAMIN E;

EID: 78651318379     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2010.0817     Document Type: Article

References (14)

1. Shayan R, Achen MG, Stacker SA. Lymphatic vessels in cancer metastasis: Bridging the gaps. Carcinogenesis 2006;7:1729.
2. Morton DL, Chan AD. The concept of sentinel lymph node localization: How it started. Semin Nucl Med 2000;30:4.
3. Veronesi U, Galimberti V, Zurrida S, et al. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 2001;37:454.
4. Alex JC The application of sentinel node radiolocalization to solid tumors of the head and neck: A 10 year experience. Laryngoscope 2004;114:2.
5. Leong SP. The role of sentinel lymph nodes in malignant melanoma. Surg Clin North Am 2000;80:1741.
6. Tornē A, Puig-Tintore LM. The use of sentinel lymph nodes in gynecological malignancies. Curr Opin Obstet Gynecol 2004;16:57.
7. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage mela-noma. Arch Surg 1992;127:392.
8. Aarsvold JN, Alazraki NP. Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med 2005;35:116.
9. Eshima D, Fauconnier T, Eshima L, et al. Radio-pharmaceuticals for lymphoscintigraphy: Including dosime-try and radiation considerations. Semin Nucl Med 2000;30:25.
10. Guerrero DQ, Allemann E, Fessi H, et al. Preparation tech-niques and mechanism of formation of biodegradable na-noparticles from preformed polymers. Drug Dev Ind Pharm 1998;24:1113.
11. Li F, Wang T, He HB, et al. The properties of bufadienolides loaded nano-emulsion and submicro-emulsion during ly-ophilization. Int J Pharm 2008;349:291.
12. Tafaghodi M, Tabassi SAS, Jaafari MR, et al. Evaluation of the clearance characteristics of various microspheres in the hu-man nose by gamma-scintigraphy. Int J Pharm 2004;280:125.
13. Zang Z, Feng SS. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succi-nate nanoparticles. Biomaterials 2006;27:4025.
14. Mu L, Feng SS. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing Vit E TPGS. J Control Release 2003;86:33.